Clinical Prognostic Score to Predict Relapse in VL
Recruiting
Observational Study
Visceral Leishmaniasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 741 (estimated)
- Sponsor
- Institute of Tropical Medicine, Belgium · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia.
Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. T…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* clinically or parasitologically confirmed VL
Exclusion Criteria:
* Age under 12 years
* VL patients already on treatment for 3 days or more
* Severe critical condition or other circumstances that make the study medically inadvisable
* Unlikely to adhere to follow up visits d…
Contacts